EPO and ischemic disease: Moreover, a study on ischemic disease in non-hematopoietic cells reported increased recovery of cell function through mitochondrial activity stimulation by an endogenous EPO inducer, indicating that EPO could be a potential therapeutic strategy for ischemic diseases [74].